Global Vitamin D Testing Market To Reach USD 1,887.61 Million By 2032, Growing At A CAGR Of 8.34% - SNS Insider


(MENAFN- GlobeNewsWire - Nasdaq) According to Research by SNS Insider, vitamin D Testing market Growth is Driven by Increasing Awareness of Vitamin D Deficiency and Advancements in Diagnostic Technology.

Austin, United States, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Vitamin D Testing Market Size Analysis:

“According to SNS Insider, The Vitamin D Testing Market was valued at USD 919.38 million in 2023 and is projected to reach USD 1887.61 million by 2032, growing at a compound annual growth rate of 8.34% over the forecast period of 2024-2032.”

Market Overview

The global Vitamin D Testing Market is experiencing significant growth due to increasing awareness of vitamin D's role in maintaining overall health. Rising cases of vitamin D deficiency and its association with chronic conditions, such as osteoporosis, cardiovascular diseases, and immune disorders, are driving demand. The convenience of at-home testing kits and advancements in diagnostic technology are bolstering supply, meeting the surging demand for timely and accurate results. Furthermore, government health initiatives emphasizing regular screenings and preventive care play a pivotal role in the market's expansion.

The demand for vitamin D testing is also fueled by its importance in managing aging-related health issues. With the growing elderly population worldwide, healthcare systems are prioritizing screening for deficiencies to address osteoporosis, fractures, and related conditions. Moreover, the advent of digital tools and online consultations has simplified access to these diagnostic solutions, further boosting market growth.


Get a Sample Report of Vitamin D Testing Market@

Key Vitamin D Testing Companies Profiled:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • DiaSorin S.p.A.
  • Beckman Coulter Inc. (BD)
  • Quest Diagnostics Incorporated
  • Tosoh Bioscience Inc.
  • Quidel Corporation
  • Danaher Corporation
  • RECIPE Chemicals + Instruments GmbH

Vitamin D Testing Market Report Scope:

Report Attributes Details
Market Size in 2023 US$ 919.38 million
Market Size by 2032 US$ 1,887.61 million
CAGR CAGR of 8.34% From 2024 to 2032
Base Year 2023
Forecast Period 2024-2032
Historical Data 2020-2022
Key Regional Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)

Segment Analysis

By Product

The 25-Hydroxy Vitamin D Test dominated the Vitamin D Testing Market with approximately 75.0% of the market share in 2023. This test remains the gold standard for assessing vitamin D levels in individuals due to its high accuracy and reliability. It is widely used in clinical settings for both routine check-ups and specialized health assessments, especially for monitoring bone health, immune function, and overall well-being.

The 1,25-Dihydroxy Vitamin D Test is expected to be the fastest-growing segment in the Vitamin D Testing Market during the forecast period. This test is increasingly utilized to diagnose specific conditions such as kidney disorders and parathyroid abnormalities, making it particularly valuable in specialized clinical scenarios.

By Technology

The ELISA (Enzyme-Linked Immunosorbent Assay) technology led the Vitamin D Testing Market in 2023, capturing 45.0% of the market share. Its popularity is attributed to its cost-effectiveness, ease of use, and efficiency in processing large sample volumes. ELISA offers reliable results and is commonly used in both clinical laboratories and research settings.

LC-MS (Liquid Chromatography-Mass Spectrometry) is rapidly gaining traction in the Vitamin D Testing Market, Known for its precision, LC-MS technology is increasingly utilized for measuring vitamin D metabolites with high accuracy, particularly in research and specialized clinical applications.

By Indication

Vitamin D Deficiency accounted for 65.0% of the market share in 2023, making it the largest segment in the Vitamin D Testing Market. The increasing awareness of the importance of vitamin D in maintaining overall health and preventing chronic conditions has driven the widespread adoption of testing for deficiency. Regular screening for vitamin D levels has become a routine practice in healthcare systems worldwide, particularly for those at risk of deficiency, such as the elderly, individuals with limited sun exposure, or those with certain chronic conditions.

The Osteoporosis indication is projected to be the fastest growing during the forecast period. This growth is driven by the rising prevalence of osteoporosis, particularly among aging populations, and the increasing recognition of vitamin D's critical role in bone health. Vitamin D plays a vital role in calcium absorption and bone mineralization, which is essential for preventing bone density loss and fractures.

Need any customization research on Vitamin D Testing Market, Enquire Now@

Vitamin D Testing Market Key Segments:

By Product

  • 25-Hydroxy Vitamin D Test
  • 1,25-Dihydroxy Vitamin D Test
  • 24,25-Dihydroxy Vitamin D Test

By Technology

  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others

By Indication

  • Osteoporosis
  • Rickets
  • Thyroid Disorders
  • Vitamin D Deficiency
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Homecare
  • Others

Regional Analysis

In 2023, North America held the largest share of the Vitamin D Testing Market, accounting for over 40.0% of the revenue. This dominance is driven by high healthcare spending, sophisticated diagnostic infrastructure, and comprehensive awareness initiatives promoting preventive health. The growing prevalence of conditions like osteoporosis and autoimmune disorders in the U.S. and Canada further boosts the demand for vitamin D testing.

Europe ranked as the second-largest market, with several countries like Germany, the UK, and France experiencing significant growth in vitamin D testing. This is largely due to proactive government policies encouraging public health screenings, as well as an aging population that faces a higher risk of deficiency-related conditions. The increasing focus on public health and preventive care across the region also supports market growth.

The Asia-Pacific region is expected to be the fastest-growing market during the forecast period, driven by increased healthcare investments and rising awareness about the importance of vitamin D. Nations such as India and China are adopting more diagnostic solutions due to urbanization and lifestyle changes, which are contributing to higher vitamin D deficiencies.

Recent Developments

In 2024, Siemens expanded its vitamin D testing portfolio with the introduction of CDC-certified assays, including the Atellica IM Vitamin D Total Assay. This assay delivers precise results for both vitamin D2 and D3, utilizing cutting-edge technology to minimize interference. It also ensures rapid results in just 14 minutes, with a high throughput capacity.


Buy a Single-User PDF of Vitamin D Testing Market Analysis & Outlook Report 2024-2032@

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy ... Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

MENAFN02122024004107003653ID1108946593


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.